<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chang CT</submitter><funding>Ministry of Science and Technology</funding><funding>Academia Sinica&amp;apos;s Stroke Biosignature Project</funding><funding>China Medical University Hospital</funding><pagination>542-550</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9296198</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(2)</volume><pubmed_abstract>High-density lipoprotein (HDL) carbamylation has been known in uremia patients. Paraoxonase-1 (PON-1) is an important HDL protein responsible for HDL anti-oxidant, arylesterase and lactonase activities. PON-1 carbamylation in uremic HDL has never been explored. We isolated HDL from uremia patients and control healthy subjects for study. Sandwich ELISA was used to estimate carbamylated PON-1 protein expression in HDL, and nanoflow liquid chromatography-tandem mass spectrometry (nanoLC-MS/MS) was applied to identify the amino acid in PON-1 carbamylated. PON-1 enzyme activities were estimated by substrates conversion method. HDL anti-oxidant activity was gauged by fluorescence changes of indicator dye in the presence of H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>. Our study results proved that the degree of P</pubmed_abstract><journal>Journal of food and drug analysis</journal><pubmed_title>PON-1 carbamylation is enhanced in HDL of uremia patients.</pubmed_title><pmcid>PMC9296198</pmcid><funding_grant_id>DMR-107-121</funding_grant_id><funding_grant_id>MOST 106-2113-M-039-001</funding_grant_id><funding_grant_id>BM10701010021</funding_grant_id><pubmed_authors>Chen CJ</pubmed_authors><pubmed_authors>Tang FY</pubmed_authors><pubmed_authors>Lee CW</pubmed_authors><pubmed_authors>Chang CT</pubmed_authors><pubmed_authors>Liao HY</pubmed_authors><pubmed_authors>Yang CY</pubmed_authors><pubmed_authors>Lim YP</pubmed_authors><pubmed_authors>Chen FY</pubmed_authors><pubmed_authors>Chang CM</pubmed_authors></additional><is_claimable>false</is_claimable><name>PON-1 carbamylation is enhanced in HDL of uremia patients.</name><description>High-density lipoprotein (HDL) carbamylation has been known in uremia patients. Paraoxonase-1 (PON-1) is an important HDL protein responsible for HDL anti-oxidant, arylesterase and lactonase activities. PON-1 carbamylation in uremic HDL has never been explored. We isolated HDL from uremia patients and control healthy subjects for study. Sandwich ELISA was used to estimate carbamylated PON-1 protein expression in HDL, and nanoflow liquid chromatography-tandem mass spectrometry (nanoLC-MS/MS) was applied to identify the amino acid in PON-1 carbamylated. PON-1 enzyme activities were estimated by substrates conversion method. HDL anti-oxidant activity was gauged by fluorescence changes of indicator dye in the presence of H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>. Our study results proved that the degree of P</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Apr</publication><modification>2025-04-25T23:43:54.655Z</modification><creation>2024-11-06T18:40:14.723Z</creation></dates><accession>S-EPMC9296198</accession><cross_references><pubmed>30987726</pubmed><doi>10.1016/j.jfda.2018.09.007</doi></cross_references></HashMap>